Virological and immunological effects of salvage therapy following treatment interruption and a shift in HIV-1 resistance genotype
- 9 September 2002
- journal article
- Published by Wiley in Journal of Medical Virology
- Vol. 68 (3) , 305-310
- https://doi.org/10.1002/jmv.10204
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Changes in Human Immunodeficiency Virus Type 1 Populations after Treatment Interruption in Patients Failing Antiretroviral TherapyJournal of Virology, 2001
- Virologic and Immunologic Consequences of Discontinuing Combination Antiretroviral-Drug Therapy in HIV-Infected Patients with Detectable ViremiaNew England Journal of Medicine, 2001
- Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failureAIDS, 2000
- Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimenAIDS, 2000
- Antiretroviral Drug Resistance Testing in Adult HIV-1 InfectionJAMA, 2000
- Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapyAIDS, 1999
- Improvement in CD4+ Cell Counts despite Persistently Detectable HIV LoadNew England Journal of Medicine, 1998
- CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART)The Lancet, 1998
- Protecting HIV databasesNature, 1995
- Avoiding false positives with PCRNature, 1989